These results are in line with previous studies suggesting that ZEB1 regulates the expression of FGFR1 in lung cancer cells [30, 31] and that EMT causes resistance to EGFR and BRAF inhibitors [32–34] as well as AMG 510 [22]. Here, ZEB1 is linked to lung carcinoma.